newsfilter
← Latest News
PR Newswire·

Disc Medicine Initiates AURORA, a Phase 2 Clinical Study of Bitopertin in Adults with Erythropoietic Protoporphyria (EPP)

AURORA study designed to evaluate bitopertin as a potential disease-modifying treatment for adults with EPP in the United StatesAURORA study designed to assess changes in protoporphyrin IX levels, safety, tolerability,